Concepedia

Amanda Watkins

AW

Statistics

Publications

9

Citations

1.4K

H-Index

9

Active since

2000

Affiliations

Altimmune (United States)(Current)

AstraZeneca (United Kingdom)

Massachusetts Medical Society

Granta Design (United Kingdom)

Amplimmune (United States)

Amanda Watkins is an author at Altimmune (United States) specializing in immunology, oncology, and tumor immunology.

Publications per year

2000–2021

9

Publications

9

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 423 citations

, , +16

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 409 citations

, , +17

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt, D. R. Shackleton Bailey, John Zielinski et al. · Clinical Cancer Research · 2020 · 218 citations · Full text

, , +17

Loss of CD4<sup>+</sup>T Cell Proliferative Ability but Not Loss of Human Immunodeficiency Virus Type 1 Specificity Equates with Progression to Disease

Jamie Wilson, Nesrina Imami, Amanda Watkins et al. · The Journal of Infectious Diseases · 2000 · 122 citations · Full text

, , +17

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Molly A. Taylor, Adina Hughes, Josephine Walton et al. · Journal for ImmunoTherapy of Cancer · 2019 · 102 citations · Full text

, , +17

1–5 of 9